Production Sites: Lexington, NC
Processes: Spunmelt
Major Markets: Medical apparel, medical devices

Under new ownership, Halyard Health announced its plan to sell its surgical and infection prevention business, including surgical gowns, drapes, sterilization solutions, gloves, face masks and protective apparel to Owens & Minor in November 2017. The sale was complete in May 2018.

Formerly a part of Kimberly-Clark, Halyard makes 57,000 tons of nonwovens in Lexington, NC, at a site which was included in the K-C spinoff. While the majority of these nonwovens are consumed internally, with the exception of a few select external customers, industry estimates put the value of its nonwovens output at $135 million per year.

Since spinning off from K-C in 2014, Halyard has made an aggregate investment of $50 million to its nonwovens operations, which included the transformation of a commodity spunbond hygiene line into a world class surgical SMS line.

These investments, along with its new partnership with Owens & Minor, have allowed Halyard to leverage its collective strengths and extensive North American footprint to provide industry leading products, service and solutions while helping its customers mitigate common supply chain risks from manufacturing to the point of care.

This experience also allows for continuous new product development featuring innovations that help improve clinician comfort, efficiency and protection.

Production Sites: Lexington, NC
Processes: Spunmelt
Major Markets: Medical apparel, medical devices

Under new ownership, Halyard Health announced its plan to sell its surgical and infection prevention business, including surgical gowns, drapes, sterilization solutions, gloves, face masks and protective apparel to Owens & Minor in November 2017. The sale was complete in May 2018.

Formerly a part of Kimberly-Clark, Halyard makes 57,000 tons of nonwovens in Lexington, NC, at a site which was included in the K-C spinoff. While the majority of these nonwovens are consumed internally, with the exception of a few select external customers, industry estimates put the value of its nonwovens output at $135 million per year.

Since spinning off from K-C in 2014, Halyard has made an aggregate investment of $50 million to its nonwovens operations, which included the transformation of a commodity spunbond hygiene line into a world class surgical SMS line.

“Halyard and now Owens & Minor, continues to make strategic large-scale capital investments to meet the changing needs of our customers and maintain our vertically integrated competitive advantage in nonwovens production and use,” says Mike Tuck, vice president, global product supply.

These investments, along with its new partnership with Owens & Minor, have allowed Halyard to leverage its collective strengths and extensive North American footprint to provide industry leading products, service and solutions while helping its customers mitigate common supply chain risks from manufacturing to the point of care.

“Additionally, by leveraging Halyard’s decades of manufacturing and innovation experience, commitment to safety and application of Lean manufacturing principles, Owens & Minor has been able to realize new efficiencies at other production sites in its network, including locations focused on the production of custom procedural trays and kits,” Tuck says.

This experience also allows for continuous new product development featuring innovations that help improve clinician comfort, efficiency and protection.

Among its latest launches is the AERO SERIES Gowns, including Aero Chrome and Aero Blue surgical gowns, that allow hospitals to manage up to 40% fewer gown codes while providing the highest level of protection for fluid-intensive procedures and ensuring staff comfort, and the Chemo 360 gown which was tested for resistance to 52 hazardous chemotherapy drugs. These gowns feature a fully-closed back, with a secure tape closure, to provide additional protection from exposure to cytotoxic drugs. Additionally, Halyard’s Smart-Fold Sterilization Wrap was designed with impact-resistant and triple-layer reinforcement zones engineered to protect the heaviest surgical trays and loaner sets from tears and cuts in handling.

Production Sites: Lexington, NC
Processes: Spunmelt
Major Markets: Medical apparel, medical devices

Under new ownership, Halyard Health announced its plan to sell its surgical and infection prevention business, including surgical gowns, drapes, sterilization solutions, gloves, face masks and protective apparel to Owens & Minor in November 2017. The sale was complete in May 2018.

Formerly a part of Kimberly-Clark, Halyard makes 57,000 tons of nonwovens in Lexington, NC, at a site which was included in the K-C spinoff. While the majority of these nonwovens are consumed internally, with the exception of a few select external customers, industry estimates put the value of its nonwovens output at $135 million per year.

Since spinning off from K-C in 2014, Halyard has made an aggregate investment of $50 million to its nonwovens operations, which included the transformation of a commodity spunbond hygiene line into a world class surgical SMS line.

“Halyard and now Owens & Minor, continues to make strategic large-scale capital investments to meet the changing needs of our customers and maintain our vertically integrated compeitive advantage in nonwovens production and use,” say Mike Tuck, vice president, global product supply.

These investments, along with its new partnership with Owens & Minor, have allowed Halyard to leverage its collective strengths and extensive North American footprint to provide industry leading products, service and solutions while helping its customers mitigate common supply chain risks from manufacturing to the point of care.

“Additionally, by leveraging Halyard’s decades of manufacturing and innovation experience, commitment to safety and application of Lean manufacturing principles, Owens & Minor has been able to realize new efficiencies at other production sites in its network, including locations focused on the production of custom procedural trays and kits,” Tuck says.

This experience also allows for continuous new product development featuring innovations that help improve clinician comfort, efficiency and protection.

Among its latest launches is the AERO SERIES Gowns, including Aero Chrome and Aero Blue surgical gowns allow hospitals to manage up to 40% fewer gown codes  while providing the highest level of protection for fluid-intensive procedures  and ensuring staff comfort, and the Chemo 360 gown which was tested for resistance to 52 hazardous chemotherapy drugs. These gowns feature a fully-closed back, with a secure tape closure, to provide additional protection from exposure to cytotoxic drugs. Additionally, Halyard’s Smart-Fold Sterilization Wrap was designed with impact-resistant and triple-layer reinforcement zones engineered to protect the heaviest surgical trays and loaner sets from tears and cuts in handling.